Evidence map›Paper›PMID 29741478›Full record

ArticleeLife2018

SRSF3 promotes pluripotency through

Madara Ratnadiwakara, Stuart K Archer, Craig I Dent, Igor Ruiz De Los Mozos, Traude H Beilharz, Anja S Knaupp, Christian M Nefzger, Jose M Polo, Minna-Liisa Anko

Open access · goldAbstract read
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Oncogenic SRSF3 in health and diseases.International journal of biological sciences · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Madara RatnadiwakaraDepartment of Anatomy and Developmental Biology, Monash University, Melbourne, Australia.ORCID http://orcid.org/0000-0001-7252-1823
Stuart K ArcherBioinformatics Platform, Monash University, Clayton, Australia.
Craig I DentSchool of Biological Sciences, Monash University, Melbourne, Australia.
Igor Ruiz De Los MozosThe Francis Crick Institute, London, United Kingdom.ORCID https://orcid.org/0000-0003-4097-6422
Traude H BeilharzBiomedicine Discovery Institute, Development and Stem Cells Program, Monash University, Melbourne, Australia.
Anja S KnauppDepartment of Anatomy and Developmental Biology, Monash University, Melbourne, Australia.
Christian M NefzgerDepartment of Anatomy and Developmental Biology, Monash University, Melbourne, Australia.
Jose M PoloDepartment of Anatomy and Developmental Biology, Monash University, Melbourne, Australia.
Minna-Liisa AnkoDepartment of Anatomy and Developmental Biology, Monash University, Melbourne, Australia.ORCID http://orcid.org/0000-0003-0446-3566
Australian Regenerative Medicine Institute · AUMonash University · AUThe Francis Crick Institute · GB

Funding

KOMP2-Phase3 Production and Phenotyping by the DTCC Consortium TCP Transfer to UC DavisUM1OD023221 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KC KENT LLOYD · 2016 to 2026
$45.7M
NIH HHS UM1 OD023221
6 · The paper itself

Abstract

The establishment and maintenance of pluripotency depend on precise coordination of gene expression. We establish serine-arginine-rich splicing factor 3 (SRSF3) as an essential regulator of RNAs encoding key components of the mouse pluripotency circuitry, SRSF3 ablation resulting in the loss of pluripotency and its overexpression enhancing reprogramming. Strikingly, SRSF3 binds to the core pluripotency transcription factor

Indexed as

Gene Expression RegulationAnimalsBiological TransportCells, CulturedEmbryonic Stem CellsMiceNanog Homeobox ProteinNucleocytoplasmic Transport ProteinsPluripotent Stem CellsProtein BindingRNA, MessengerRNA SplicingSerine-Arginine Splicing FactorsNanog Homeobox ProteinNanog protein, mouseNucleocytoplasmic Transport ProteinsNXF1 protein, mouseRNA, MessengerSerine-Arginine Splicing FactorsSrsf3 protein, mousealternative splicingchromosomesdevelopmental biologygene expressionmousemRNA exportpluripotentreprogrammingRNA processingSR proteinstem cells

Identifiers

PMID29741478
PMCPMC5963917
OpenAlexW2800683083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.